The U.S. Food and Drug Administration has reissued two temporary guidances originally published during the COVID-19 public health emergency (PHE) for certain regulatory requirements that involve onsite visits abroad under the Food Safety Modernization Act (FSMA).
Following a May 2023 announcement of a new framework for systematic post-market reassessment for chemicals used in foods, the U.S. Food and Drug Administration (FDA) has released a public inventory of certain food ingredients and additives determined to have unsafe uses in food because they are unapproved, as well as lists of select chemicals currently under the agency’s review. FDA also shared insights about the agency’s work to enhance the assessment of ingredients in foods on the market.
The U.S. Food and Drug Administration’s (FDA’s) Center for Food Safety and Applied Nutrition (CFSAN) and Office of Food Policy and Response (OFPR) have released an updated list of draft and final guidance topics that are a priority for the FDA Foods Program to complete during 2023. The list updates the guidance agenda released in February 2023 and focuses on Level 1 draft and final guidances.
The U.S. Food and Drug Administration (FDA) has provided updates on the agency’s Cyclospora Prevention, Response, and Research Action Plan to reflect the current status of the agency’s work to prevent and reduce incidences of foodborne cyclosporiasis in the U.S.
A molecular sample-to-answer method developed by Rheonix Inc. and the U.S. Food and Drug Administration (FDA) enables low-level detection of Cyclospora in food and environmental samples.
The U.S. Food and Drug Administration has provided updates on its proposal to create a unified Human Foods Program (HFP), which includes a new model for the Office of Regulatory Affairs (ORA).
The U.S. Food and Drug Administration (FDA) has posted answers to frequently asked questions (FAQs) and additional tools to provide industry with more information about the FDA Food Safety Modernization Act (FSMA) Food Traceability Final Rule, also known as FSMA 204.
The U.S. Food and Drug Administration (FDA) has published a report on the occurrence of foodborne illness risk factors in fast food and full-service restaurants from 2017–2018. The study found FSMS to be the strongest predictor of compliance, with well-developed FSMSs associated with fewer out-of-compliance food safety behaviors/practice than those underdeveloped or non-existent FSMS.
U.S. Representative Rosa DeLauro (CT-03) has reintroduced the Expanded Food Safety Investigation Act, which would give the U.S. Food and Drug Administration (FDA) the authority to investigate corporate livestock feedlots and confinement operations implicated in foodborne illness outbreaks.
The U.S. Food and Drug Administration (FDA) recently released the findings of a sampling assignment that collected and tested ready-to-eat (RTE) dips and spreads with the aim of determining the presence of Listeria monocytogenes and Salmonella.
RSS
